Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?
Esophageal cancer (EC), as one of the leading causes of cancer‐associated mortality, influences a remarkable population of subjects globally and is histologically divided into two types, comprising esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). Although several therap...
Gespeichert in:
| Veröffentlicht in: | Cell biology international 2023-04, Vol.47 (4), p.714-719 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 719 |
|---|---|
| container_issue | 4 |
| container_start_page | 714 |
| container_title | Cell biology international |
| container_volume | 47 |
| creator | ArefNezhad, Reza Rezaei‐Tazangi, Fatemeh Roghani‐Shahraki, Hossein Goleij, Pouya Zare, Nabi Motedayyen, Hossein Aghazadeh, Elaheh |
| description | Esophageal cancer (EC), as one of the leading causes of cancer‐associated mortality, influences a remarkable population of subjects globally and is histologically divided into two types, comprising esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). Although several therapeutic approaches are present for EC, such as radiotherapy, chemotherapy, and surgery, these options have low success with serious side effects, for example, gastrointestinal toxicity, esophagitis, and pulmonary complications. Thus, utilizing an effective tool with low side effects is urgent. Newly, mesenchymal stem cells (MSCs) have received special interest for treating diverse diseases, such as cancer. Among different sources of MSCs, human umbilical cord MSCs have notable benefits, and reports expressed that they may be effective in EC treatment. For this purpose, in this review study, we aimed to summarize evidence regarding the effects of human umbilical cord MSCs on EC with a mechanistic insight. |
| doi_str_mv | 10.1002/cbin.11991 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2771331997</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2781117632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3571-77a9b7e8cbb3ce7ac5f9a2f0d783f071cae5009cb3e0e6a9e80757f59d93926c3</originalsourceid><addsrcrecordid>eNp9kM9L5DAUgIOs-Puyf8AS2IsI1bzGNI2XZR3UEUQvei5p-joTadIxaZX5700ddw8ePL3w-PLx-Aj5CewUGMvPTG39KYBSsEX2gCmRlVyIH9O7EFmhlNgl-zE-MwZwXhY7ZJcXEkpWsj2ynI9Oezq62nbW6I6aPjTUYURvlmuXFnFARw12Xbygcwy6a6xf0PQH2xbNYF-RDgH14NAPVC-09XGgGPvVUi9wEmpvMPw5JNut7iIefc4D8nR99TibZ3cPN7ezv3eZ4UJCJqVWtcTS1DU3KLURrdJ5yxpZ8pZJMBoFY8rUHBkWWmHJpJCtUI3iKi8MPyDHG-8q9C8jxqFyNk7na4_9GKtcSuA8xZIJ_f0Ffe7H4NN1iSoBQBY8T9TJhjKhjzFgW62CdTqsK2DV1L-a-lcf_RP861M51g6b_-i_4AmADfBmO1x_o6pml7f3G-k7RCGQvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2781117632</pqid></control><display><type>article</type><title>Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>ArefNezhad, Reza ; Rezaei‐Tazangi, Fatemeh ; Roghani‐Shahraki, Hossein ; Goleij, Pouya ; Zare, Nabi ; Motedayyen, Hossein ; Aghazadeh, Elaheh</creator><creatorcontrib>ArefNezhad, Reza ; Rezaei‐Tazangi, Fatemeh ; Roghani‐Shahraki, Hossein ; Goleij, Pouya ; Zare, Nabi ; Motedayyen, Hossein ; Aghazadeh, Elaheh</creatorcontrib><description>Esophageal cancer (EC), as one of the leading causes of cancer‐associated mortality, influences a remarkable population of subjects globally and is histologically divided into two types, comprising esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). Although several therapeutic approaches are present for EC, such as radiotherapy, chemotherapy, and surgery, these options have low success with serious side effects, for example, gastrointestinal toxicity, esophagitis, and pulmonary complications. Thus, utilizing an effective tool with low side effects is urgent. Newly, mesenchymal stem cells (MSCs) have received special interest for treating diverse diseases, such as cancer. Among different sources of MSCs, human umbilical cord MSCs have notable benefits, and reports expressed that they may be effective in EC treatment. For this purpose, in this review study, we aimed to summarize evidence regarding the effects of human umbilical cord MSCs on EC with a mechanistic insight.</description><identifier>ISSN: 1065-6995</identifier><identifier>EISSN: 1095-8355</identifier><identifier>DOI: 10.1002/cbin.11991</identifier><identifier>PMID: 36718080</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adenocarcinoma ; Adenocarcinoma - pathology ; Chemotherapy ; Esophageal cancer ; Esophageal Neoplasms - pathology ; Esophageal Squamous Cell Carcinoma - pathology ; Esophagitis ; Esophagus ; Humans ; Mesenchymal Stem Cell Transplantation ; Mesenchymal Stem Cells ; Radiation therapy ; Side effects ; Squamous cell carcinoma ; Stem cells ; Toxicity ; Umbilical Cord</subject><ispartof>Cell biology international, 2023-04, Vol.47 (4), p.714-719</ispartof><rights>2023 International Federation for Cell Biology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3571-77a9b7e8cbb3ce7ac5f9a2f0d783f071cae5009cb3e0e6a9e80757f59d93926c3</citedby><cites>FETCH-LOGICAL-c3571-77a9b7e8cbb3ce7ac5f9a2f0d783f071cae5009cb3e0e6a9e80757f59d93926c3</cites><orcidid>0000-0003-1402-6482</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcbin.11991$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcbin.11991$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36718080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ArefNezhad, Reza</creatorcontrib><creatorcontrib>Rezaei‐Tazangi, Fatemeh</creatorcontrib><creatorcontrib>Roghani‐Shahraki, Hossein</creatorcontrib><creatorcontrib>Goleij, Pouya</creatorcontrib><creatorcontrib>Zare, Nabi</creatorcontrib><creatorcontrib>Motedayyen, Hossein</creatorcontrib><creatorcontrib>Aghazadeh, Elaheh</creatorcontrib><title>Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?</title><title>Cell biology international</title><addtitle>Cell Biol Int</addtitle><description>Esophageal cancer (EC), as one of the leading causes of cancer‐associated mortality, influences a remarkable population of subjects globally and is histologically divided into two types, comprising esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). Although several therapeutic approaches are present for EC, such as radiotherapy, chemotherapy, and surgery, these options have low success with serious side effects, for example, gastrointestinal toxicity, esophagitis, and pulmonary complications. Thus, utilizing an effective tool with low side effects is urgent. Newly, mesenchymal stem cells (MSCs) have received special interest for treating diverse diseases, such as cancer. Among different sources of MSCs, human umbilical cord MSCs have notable benefits, and reports expressed that they may be effective in EC treatment. For this purpose, in this review study, we aimed to summarize evidence regarding the effects of human umbilical cord MSCs on EC with a mechanistic insight.</description><subject>Adenocarcinoma</subject><subject>Adenocarcinoma - pathology</subject><subject>Chemotherapy</subject><subject>Esophageal cancer</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Squamous Cell Carcinoma - pathology</subject><subject>Esophagitis</subject><subject>Esophagus</subject><subject>Humans</subject><subject>Mesenchymal Stem Cell Transplantation</subject><subject>Mesenchymal Stem Cells</subject><subject>Radiation therapy</subject><subject>Side effects</subject><subject>Squamous cell carcinoma</subject><subject>Stem cells</subject><subject>Toxicity</subject><subject>Umbilical Cord</subject><issn>1065-6995</issn><issn>1095-8355</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM9L5DAUgIOs-Puyf8AS2IsI1bzGNI2XZR3UEUQvei5p-joTadIxaZX5700ddw8ePL3w-PLx-Aj5CewUGMvPTG39KYBSsEX2gCmRlVyIH9O7EFmhlNgl-zE-MwZwXhY7ZJcXEkpWsj2ynI9Oezq62nbW6I6aPjTUYURvlmuXFnFARw12Xbygcwy6a6xf0PQH2xbNYF-RDgH14NAPVC-09XGgGPvVUi9wEmpvMPw5JNut7iIefc4D8nR99TibZ3cPN7ezv3eZ4UJCJqVWtcTS1DU3KLURrdJ5yxpZ8pZJMBoFY8rUHBkWWmHJpJCtUI3iKi8MPyDHG-8q9C8jxqFyNk7na4_9GKtcSuA8xZIJ_f0Ffe7H4NN1iSoBQBY8T9TJhjKhjzFgW62CdTqsK2DV1L-a-lcf_RP861M51g6b_-i_4AmADfBmO1x_o6pml7f3G-k7RCGQvg</recordid><startdate>202304</startdate><enddate>202304</enddate><creator>ArefNezhad, Reza</creator><creator>Rezaei‐Tazangi, Fatemeh</creator><creator>Roghani‐Shahraki, Hossein</creator><creator>Goleij, Pouya</creator><creator>Zare, Nabi</creator><creator>Motedayyen, Hossein</creator><creator>Aghazadeh, Elaheh</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1402-6482</orcidid></search><sort><creationdate>202304</creationdate><title>Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?</title><author>ArefNezhad, Reza ; Rezaei‐Tazangi, Fatemeh ; Roghani‐Shahraki, Hossein ; Goleij, Pouya ; Zare, Nabi ; Motedayyen, Hossein ; Aghazadeh, Elaheh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3571-77a9b7e8cbb3ce7ac5f9a2f0d783f071cae5009cb3e0e6a9e80757f59d93926c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adenocarcinoma</topic><topic>Adenocarcinoma - pathology</topic><topic>Chemotherapy</topic><topic>Esophageal cancer</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Squamous Cell Carcinoma - pathology</topic><topic>Esophagitis</topic><topic>Esophagus</topic><topic>Humans</topic><topic>Mesenchymal Stem Cell Transplantation</topic><topic>Mesenchymal Stem Cells</topic><topic>Radiation therapy</topic><topic>Side effects</topic><topic>Squamous cell carcinoma</topic><topic>Stem cells</topic><topic>Toxicity</topic><topic>Umbilical Cord</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ArefNezhad, Reza</creatorcontrib><creatorcontrib>Rezaei‐Tazangi, Fatemeh</creatorcontrib><creatorcontrib>Roghani‐Shahraki, Hossein</creatorcontrib><creatorcontrib>Goleij, Pouya</creatorcontrib><creatorcontrib>Zare, Nabi</creatorcontrib><creatorcontrib>Motedayyen, Hossein</creatorcontrib><creatorcontrib>Aghazadeh, Elaheh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cell biology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ArefNezhad, Reza</au><au>Rezaei‐Tazangi, Fatemeh</au><au>Roghani‐Shahraki, Hossein</au><au>Goleij, Pouya</au><au>Zare, Nabi</au><au>Motedayyen, Hossein</au><au>Aghazadeh, Elaheh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?</atitle><jtitle>Cell biology international</jtitle><addtitle>Cell Biol Int</addtitle><date>2023-04</date><risdate>2023</risdate><volume>47</volume><issue>4</issue><spage>714</spage><epage>719</epage><pages>714-719</pages><issn>1065-6995</issn><eissn>1095-8355</eissn><abstract>Esophageal cancer (EC), as one of the leading causes of cancer‐associated mortality, influences a remarkable population of subjects globally and is histologically divided into two types, comprising esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). Although several therapeutic approaches are present for EC, such as radiotherapy, chemotherapy, and surgery, these options have low success with serious side effects, for example, gastrointestinal toxicity, esophagitis, and pulmonary complications. Thus, utilizing an effective tool with low side effects is urgent. Newly, mesenchymal stem cells (MSCs) have received special interest for treating diverse diseases, such as cancer. Among different sources of MSCs, human umbilical cord MSCs have notable benefits, and reports expressed that they may be effective in EC treatment. For this purpose, in this review study, we aimed to summarize evidence regarding the effects of human umbilical cord MSCs on EC with a mechanistic insight.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36718080</pmid><doi>10.1002/cbin.11991</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-1402-6482</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1065-6995 |
| ispartof | Cell biology international, 2023-04, Vol.47 (4), p.714-719 |
| issn | 1065-6995 1095-8355 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2771331997 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Adenocarcinoma Adenocarcinoma - pathology Chemotherapy Esophageal cancer Esophageal Neoplasms - pathology Esophageal Squamous Cell Carcinoma - pathology Esophagitis Esophagus Humans Mesenchymal Stem Cell Transplantation Mesenchymal Stem Cells Radiation therapy Side effects Squamous cell carcinoma Stem cells Toxicity Umbilical Cord |
| title | Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T06%3A16%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20umbilical%20cord%20mesenchymal%20stem%20cells:%20Heralding%20an%20effective%20treatment%20against%20esophageal%20cancer?&rft.jtitle=Cell%20biology%20international&rft.au=ArefNezhad,%20Reza&rft.date=2023-04&rft.volume=47&rft.issue=4&rft.spage=714&rft.epage=719&rft.pages=714-719&rft.issn=1065-6995&rft.eissn=1095-8355&rft_id=info:doi/10.1002/cbin.11991&rft_dat=%3Cproquest_cross%3E2781117632%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2781117632&rft_id=info:pmid/36718080&rfr_iscdi=true |